£48.28

University of Michigan Press Waiting for Cancer to Come: Women's Experiences with Genetic Testing and Medical Decision Making for Breast and Ovarian Cancer

Price data last checked 23 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£48 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 68 days · 68 data points (no recent data)

Historical
Generating forecast…
£48.28 £45.87 £46.83 £47.80 £48.76 £49.73 £50.69 02 May 2026 18 May 2026 04 June 2026 21 June 2026 08 July 2026

Price Distribution

Price distribution over 68 days • 1 price levels

Days at Price
68 days 0 17 34 51 68 £48 Days at Price

Price Analysis

Most common price: £48 (68 days, 100.0%)

Price range: £48 - £48

Price levels: 1 different prices over 68 days

Description

Waiting for Cancer to Come tells the stories of women who are struggling with their high risk for cancer. Based on interviews and surveys of dozens of women, this book pieces together the diverse yet interlocking experiences of women who have tested positive for the BRCA 1/2 gene mutations, which indicate a higher risk of developing breast and ovarian cancer. Sharlene Hesse-Biber brings these narratives to light and follows women’s journeys from deciding to get screened for BRCA, to learning the test has come back positive, to dealing with their risk. Many women already know the challenges of a family history riddled with cancer and now find themselves with the devastating knowledge of their own genetic risk. Using the voices of the women themselves to describe the under-explored BRCA experience, Waiting for Cancer to Come looks at the varied emotional, social, economic, and psychological factors at play in women’s decisions about testing and cancer prevention. Review Winner, Alpha Sigma Nu National Book Award, 2015-- "The Association of Jesuit Colleges and Universities (AJCU) Alpha Sigma Nu National Book Award""Waiting for Cancer to Come is an outstanding accomplishment. Sharlene Hesse-Biber innovatively weaves the interviews with research on the genetic testing industry and new ways in which one can think about breast cancer and the pharmaceutical/BRCA testing industries that accompany this epidemic. She is very well versed in interviewing techniques, as well as in conducting archival and related research. The documentation of the research and how it was conducted makes it possible for readers to know exactly what was done, when, and how the analysis has been pursued, and to be able to put together these disparate sources is a real tour de force!" --Kum-Kum Bhavnani, University of California, Santa Barbara-- "Kum-Kum Bhavnani, University of California, Santa Barbara""I highly recommend this book to doctors, genetic counselors, advocates, and anyone else interested in truly understanding the complexity behind the variables of genetic testing." ---Georgia Hurst, Beyond Risk--Georgia Hurst "Beyond Risk""Sociologist Hesse-Biber is well regarded for her work on research methodologies ... Her most recent book, Waiting for Cancer to Come, presents qualitative analysis of over 60 in-depth interviews with women who have tested positive for genetic mutations that increase their risk of developing breast or ovarian cancer, and effectively demonstrates feminist, mixed-methods research. ... Throughout the rest of the book, Hesse-Biber prioritizes the voices and experiences of women as they calculate their cancer risk, make decisions to undergo major surgery or opt for increased surveillance, and negotiate the new normal of their lives after a positive test." ---CHOICE--A. M. Baldwin, Indiana University, Bloomington "CHOICE""From the beginning poem and compelling anecdote to the conclusion, Sharlene Hesse-Biber tells an absorbing story of issues and events leading to or avoiding testing for the BRCA genetic mutation in her interviewees' lives. She gives the reader an intimate view of women's (and several men's) lives, offers a sensitive analysis of their situations, and explains the implications of their choices. Professor Hesse-Biber dispels any notion that women with the BRCA mutation or those with other types of breast cancer face the same questions. Instead, their specific situations, goals, and relationships shape how they respond to the test and to waiting for and having cancer. This book reveals the ambiguities and ambivalent choices that testing positive causes and confirms that testing negative does not necessarily put an end to ominous questions. Waiting for Cancer to Come shows how hard it is to choose between treatment alternatives. No treatment choice ends uncertainty for these women, even though some women try to view their treatment, such as seeking a prophylactic mastectomy, as symboli

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
30 August 2014
Listed Since
31 January 2014

Barcode

No barcode data available

Similar Products You Might Like

Breast Cancer - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
96% match

Breast Cancer - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References

£86.95 14 Jul 2026
Etiology of Breast and Gynecological Cancers (Progress in Clinical and Biological Research)
96% match

Etiology of Breast and Gynecological Cancers (Progress in Clinical and Biological Research)

Wiley-Blackwell

£181.49 09 Jul 2026
Breast Disease: Management and Therapies, Volume 2
96% match

Breast Disease: Management and Therapies, Volume 2

Springer

£144.90 13 Jul 2026
Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)
96% match

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)

Springer

£52.63 03 Jul 2026
Breast Cancer: Multidisciplinary Pathways for Cancer Care in the Community: Multidisciplinary Pathways for Cancer Care in the Community
96% match

Breast Cancer: Multidisciplinary Pathways for Cancer Care in the Community: Multidisciplinary Pathways for Cancer Care in the Community

Elsevier

£138.37 13 Jul 2026
Breast Cancer: Molecular Genetics, Pathogenesis, and Therapeutics (Contemporary Cancer Research)
96% match

Breast Cancer: Molecular Genetics, Pathogenesis, and Therapeutics (Contemporary Cancer Research)

Humana

£162.59 10 Jul 2026
Breast Cancer: Methods and Protocols: 1406 (Methods in Molecular Biology, 1406)
96% match

Breast Cancer: Methods and Protocols: 1406 (Methods in Molecular Biology, 1406)

Humana

£79.50 06 Jul 2026
Diagnostic Pathology: Breast 4th Ed - Essential Clinical Reference
96% match

Diagnostic Pathology: Breast 4th Ed - Essential Clinical Reference

Elsevier

£160.91 25 Jun 2026
Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer: 61 (Cancer Treatment and Research, 61)
96% match

Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer: 61 (Cancer Treatment and Research, 61)

Springer

£227.72 29 Jun 2026
Clinical Cancer Prevention: 188 (Recent Results in Cancer Research, 188)
96% match

Clinical Cancer Prevention: 188 (Recent Results in Cancer Research, 188)

Springer

£80.66 15 Jul 2026
Breast Cancer: Cellular and Molecular Biology: 40 (Cancer Treatment and Research, 40)
96% match

Breast Cancer: Cellular and Molecular Biology: 40 (Cancer Treatment and Research, 40)

Springer

£149.65 14 Jul 2026
Techniques and Methodological Approaches in Breast Cancer Research
96% match

Techniques and Methodological Approaches in Breast Cancer Research

Springer

£107.98 22 Jun 2026
Breast Cancer, a Heterogeneous Disease Entity: The Very Early Stages
96% match

Breast Cancer, a Heterogeneous Disease Entity: The Very Early Stages

Springer

£147.11 18 Jun 2026
Breast Disease: Management and Therapies, Volume 2
96% match

Breast Disease: Management and Therapies, Volume 2

Springer

£114.10 04 Jul 2026
Psycho-Oncology: 197 (Recent Results in Cancer Research)
96% match

Psycho-Oncology: 197 (Recent Results in Cancer Research)

Springer

£73.13 04 Jul 2026
Adjuvant Therapy of Breast Cancer IV: 127 (Recent Results in Cancer Research, 127)
96% match

Adjuvant Therapy of Breast Cancer IV: 127 (Recent Results in Cancer Research, 127)

Springer

£76.41 09 Jul 2026
Global Oncology: Disparities, Outcomes and Innovations Around the Globe, An Issue of Hematology/Oncology Clinics of North America: Volume 38-1 (The Clinics: Internal Medicine, Volume 38-1)
95% match

Global Oncology: Disparities, Outcomes and Innovations Around the Globe, An Issue of Hematology/Oncology Clinics of North America: Volume 38-1 (The Clinics: Internal Medicine, Volume 38-1)

Elsevier

£72.20 07 Jul 2026
Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)
95% match

Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)

Springer

£140.72 09 Jul 2026
Common Issues in Breast Cancer Survivors: A Practical Guide to Evaluation and Management
95% match

Common Issues in Breast Cancer Survivors: A Practical Guide to Evaluation and Management

Springer

£80.65 04 Jul 2026
Recent Advances in Clinical Oncology, Volume 1138 (Annals of the New York Academy of Sciences)
95% match

Recent Advances in Clinical Oncology, Volume 1138 (Annals of the New York Academy of Sciences)

Wiley-Blackwell

£114.50 10 Jul 2026
Prognostic Factors in Cancer (UICC)
95% match

Prognostic Factors in Cancer (UICC)

Wiley

£75.69 09 Jul 2026
Routledge Psychosocial Resource Variables in Cancer Studies
95% match

Routledge Psychosocial Resource Variables in Cancer Studies

Routledge

£135.54 15 Jul 2026
Molecular Pathology of Breast Cancer
95% match

Molecular Pathology of Breast Cancer

Springer

£108.92 19 Jun 2026
Early Breast Cancer: From Screening to Multidisciplinary Management, Third Edition
95% match

Early Breast Cancer: From Screening to Multidisciplinary Management, Third Edition

CRC Press

£63.11 13 Jul 2026